The immune cell atlas of human neuroblastoma

by Baryawno, N., Fard, S.S, Gisselsson, D., Gustafsson, K., Hagerling, C., Johnsen, J.I, Kharchenko, P.V, Kogner, P., Lindström, A., Mei, S., Olsen, T.K, Valind, A., Verhoeven, B.M
Published 2022

Drug metabolism-related eight-gene signature can predict the prognosis of gastric adenocarcinoma

by Chen, J., He, Q., Hu, X., Li, Z., Yang, W., Yin, H.-M
Published 2021

Development and verification of a hypoxia- and immune-associated prognosis signature for esophageal squamous cell carcinoma

by Han, S.-G, Lian, L., Shen, X.-M, Teng, S.-B, Wang, W.-J, Xia, Y.-Y, Xu, X.-F, Zheng, Y., Zhou, C.
Published 2022

N-6 methylation-related lncRNA is potential signature in lung adenocarcinoma and influences tumor microenvironment

by Guo, M., Li, Z., Ming, L., Qin, Z., Wan, J., Wang, Y., Yang, Z., Zhao, Z., Zheng, J.
Published 2021

A mutation-based gene set predicts survival benefit after immunotherapy across multiple cancers and reveals the immune response landscape

by Bian, J., Chen, P., Lin, Y., Long, J., Sang, X., Wang, A., Wang, D., Yang, X., Zhang, H., Zhao, H., Zheng, M., Zheng, Y.
Published 2022

A prognostic model based on seven immune-related genes predicts the overall survival of patients with hepatocellular carcinoma

by Luo, H., Wang, B., Wang, X., Yan, Q., Yang, X., Ye, B., Zhang, P., Zheng, W.
Published 2021

Comprehensive analysis of N6-methyladenosine-related long non-coding RNAs for prognosis prediction in liver hepatocellular carcinoma

by Lu, W.-J, Yu, S., Zhu, H.-X, Zhu, W.-P
Published 2021

Improved prognosis and evidence of enhanced immunogenicity in tumor and circulation of high-risk melanoma patients with unknown primary

by Butterfield, L.H, Conejo-Garcia, J.R, El Naqa, I.M, Hwu, P., Karunamurthy, A.D, Kirkwood, J.M, Laframboise, W.A, Lee, S.J, Sondak, V.K, Stephen Hodi, F., Storkus, W.J, Streicher, H., Tan, A.-C, Tarhini, A.A
Published 2022

Characterization of the immune response in patients with cancer of the oral cavity after neoadjuvant immunotherapy with the IRX-2 regimen

by Bellile, E., Bryan Bell, R., Campos, C.Z, Cernea, C.R, Cruz, F.J.S.M, D'Silva, N., Erman, A., Girotto, G.C, Higgins, K., Kaplan, M., Kraus, D., Krempl, G., Liu, S., Martins, W.A, McCaul, J., Moyer, J., Newman, J., Nguyen, A., Nieva, J., Oliveira, F., Panwar, A., Patel, M., Rozek, L., Sartor, M.A, the INSPIRE Trial Clinical Investigators, Valentino, J., Victorina, A.P, Wolf, G.T, Zarins, K.
Published 2021